Researchers say early deep brain stimulation and emerging therapies could reshape expectations for patients diagnosed in the U.S.

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

How many people in the United States are living with Parkinson’s Disease? According to statistics provided by the American ...

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 ...

Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to ...

Parkinson's disease, a progressive neurological disorder affecting more than 1 million people in the U.S. and more than 10 ...

A new stem cell treatment could offer hope for people living with Parkinson’s - More than 1 million Americans live with the ...

Scientists have found a key brain network that’s disrupted by Parkinson’s disease, according to a study published today in ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...

Parkinson's disease does more than cause tremor and trouble walking. It can also affect sleep, smell, digestion and even ...

Keck Medicine of USC is conducting an early phase clinical trial investigating the safety and effectiveness ...